Human African Trypanosomiasis (Sleeping Sickness) : The Road to Elimination Revisited-Achievements and Remaining Challenges
As it is a goal to eliminate human African trypanosomiasis (HAT; sleeping sickness) as a public health problem by 2020 and interrupt transmission by 2030, this is a good moment to reflect on what we have achieved, what we want to achieve, and what could get in our way. HAT has a reputation for spect...
Saved in:
Sonstige: | |
---|---|
Year of Publication: | 2020 |
Language: | English |
Physical Description: | 1 electronic resource (280 p.) |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
993545792404498 |
---|---|
ctrlnum |
(CKB)5400000000041155 (oapen)https://directory.doabooks.org/handle/20.500.12854/68624 (EXLCZ)995400000000041155 |
collection |
bib_alma |
record_format |
marc |
spelling |
Burri, Christian edt Human African Trypanosomiasis (Sleeping Sickness) The Road to Elimination Revisited-Achievements and Remaining Challenges Human African Trypanosomiasis Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2020 1 electronic resource (280 p.) text txt rdacontent computer c rdamedia online resource cr rdacarrier As it is a goal to eliminate human African trypanosomiasis (HAT; sleeping sickness) as a public health problem by 2020 and interrupt transmission by 2030, this is a good moment to reflect on what we have achieved, what we want to achieve, and what could get in our way. HAT has a reputation for spectacular reappearances, and the latest peak of 40,000 reported and over 300,000 estimated cases only dates back to 1998. Efforts of the WHO and partners as well as the development of simpler and much better-tolerated treatments, improved diagnostics, and vector control tools made it possible to reduce this number by 95%. Case identification and confirmation remain complex and require specific skills, treatment remains error-prone and reports on long-term survivors have emerged, and the relevance of the animal reservoir for T. b. gambiense HAT needs clarification. In addition, to win the “end game” against this massively stigmatized disease, the human factor will play a key role. This Special Issue addresses many of the burning topics about disease elimination in its 12 research and 7 review articles and one case study. The papers critically reflect the approaches used, investigate the mentioned challenges, and propose novel approaches and interventions from various points of view. English Medicine bicssc Epidemiology & medical statistics bicssc (+)-spectaline iso-6-spectaline Trypanosoma brucei rhodesiense autophagy apoptosis cross-talk trypanosomosis iron transferrin transferrin receptor nutritional immunity flagellar pocket Human African Trypanosomiasis (HAT) mydriasis neurological signs eradication re-emergence human African trypanosomiasis treatment melarsoprol adverse event encephalopathy human leukocyte antigen association study disease elimination disease eradication frontline workers DR Congo mobile screening qualitative methods sequelae serology oligosymptomatic HAT product development partnerships research and development medical innovation donor policy African trypanosomiasis sleeping sickness trypanosoma brucei drugs drug resistance history human Africa trypanosomiasis fexinidazole home-based treatment patient-centred care Uganda elimination T. b. gambiense g-HAT T. b. rhodesiense r-HAT neglected tropical diseases Trypanosoma brucei drug discovery high-throughput screening blood-brain barrier brain permeability pharmacology phenotypic drug screening Haemoparasites animal reservoirs Trypanosoma growth inhibitors chemotherapy pafuramidine acoziborole African sleeping sickness development of treatment suramin medical history political history clinical research health system strengthening South Sudan diagnosis symptoms treatment-seeking case detection embodiment expertise serendipity CATT positive serological suspects active follow-up strategy 3-03928-963-2 3-03928-964-0 Burri, Christian oth |
language |
English |
format |
eBook |
author2 |
Burri, Christian |
author_facet |
Burri, Christian |
author2_variant |
c b cb |
author2_role |
Sonstige |
title |
Human African Trypanosomiasis (Sleeping Sickness) The Road to Elimination Revisited-Achievements and Remaining Challenges |
spellingShingle |
Human African Trypanosomiasis (Sleeping Sickness) The Road to Elimination Revisited-Achievements and Remaining Challenges |
title_sub |
The Road to Elimination Revisited-Achievements and Remaining Challenges |
title_full |
Human African Trypanosomiasis (Sleeping Sickness) The Road to Elimination Revisited-Achievements and Remaining Challenges |
title_fullStr |
Human African Trypanosomiasis (Sleeping Sickness) The Road to Elimination Revisited-Achievements and Remaining Challenges |
title_full_unstemmed |
Human African Trypanosomiasis (Sleeping Sickness) The Road to Elimination Revisited-Achievements and Remaining Challenges |
title_auth |
Human African Trypanosomiasis (Sleeping Sickness) The Road to Elimination Revisited-Achievements and Remaining Challenges |
title_alt |
Human African Trypanosomiasis |
title_new |
Human African Trypanosomiasis (Sleeping Sickness) |
title_sort |
human african trypanosomiasis (sleeping sickness) the road to elimination revisited-achievements and remaining challenges |
publisher |
MDPI - Multidisciplinary Digital Publishing Institute |
publishDate |
2020 |
physical |
1 electronic resource (280 p.) |
isbn |
3-03928-963-2 3-03928-964-0 |
illustrated |
Not Illustrated |
work_keys_str_mv |
AT burrichristian humanafricantrypanosomiasissleepingsicknesstheroadtoeliminationrevisitedachievementsandremainingchallenges AT burrichristian humanafricantrypanosomiasis |
status_str |
n |
ids_txt_mv |
(CKB)5400000000041155 (oapen)https://directory.doabooks.org/handle/20.500.12854/68624 (EXLCZ)995400000000041155 |
carrierType_str_mv |
cr |
is_hierarchy_title |
Human African Trypanosomiasis (Sleeping Sickness) The Road to Elimination Revisited-Achievements and Remaining Challenges |
author2_original_writing_str_mv |
noLinkedField |
_version_ |
1787548485705269248 |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>05163nam-a2201321z--4500</leader><controlfield tag="001">993545792404498</controlfield><controlfield tag="005">20231214133130.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2020 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000041155</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68624</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000041155</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Burri, Christian</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Human African Trypanosomiasis (Sleeping Sickness)</subfield><subfield code="b">The Road to Elimination Revisited-Achievements and Remaining Challenges</subfield></datafield><datafield tag="246" ind1=" " ind2=" "><subfield code="a">Human African Trypanosomiasis </subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2020</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (280 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">As it is a goal to eliminate human African trypanosomiasis (HAT; sleeping sickness) as a public health problem by 2020 and interrupt transmission by 2030, this is a good moment to reflect on what we have achieved, what we want to achieve, and what could get in our way. HAT has a reputation for spectacular reappearances, and the latest peak of 40,000 reported and over 300,000 estimated cases only dates back to 1998. Efforts of the WHO and partners as well as the development of simpler and much better-tolerated treatments, improved diagnostics, and vector control tools made it possible to reduce this number by 95%. Case identification and confirmation remain complex and require specific skills, treatment remains error-prone and reports on long-term survivors have emerged, and the relevance of the animal reservoir for T. b. gambiense HAT needs clarification. In addition, to win the “end game” against this massively stigmatized disease, the human factor will play a key role. This Special Issue addresses many of the burning topics about disease elimination in its 12 research and 7 review articles and one case study. The papers critically reflect the approaches used, investigate the mentioned challenges, and propose novel approaches and interventions from various points of view.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Epidemiology & medical statistics</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">(+)-spectaline</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iso-6-spectaline</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Trypanosoma brucei rhodesiense</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">autophagy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">apoptosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cross-talk</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">trypanosomosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">iron</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">transferrin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">transferrin receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">nutritional immunity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">flagellar pocket</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Human African Trypanosomiasis (HAT)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mydriasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neurological signs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">eradication</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">re-emergence</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human African trypanosomiasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">melarsoprol</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adverse event</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">encephalopathy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human leukocyte antigen</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">association study</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">disease elimination</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">disease eradication</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">frontline workers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DR Congo</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">mobile screening</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">qualitative methods</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sequelae</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">serology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oligosymptomatic HAT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">product development partnerships</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">research and development</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">medical innovation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">donor policy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">African trypanosomiasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">sleeping sickness</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">trypanosoma brucei</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drugs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">history</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">human Africa trypanosomiasis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">fexinidazole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">home-based treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">patient-centred care</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Uganda</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">elimination</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">T. b. gambiense</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">g-HAT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">T. b. rhodesiense</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">r-HAT</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">neglected tropical diseases</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Trypanosoma brucei</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug discovery</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">high-throughput screening</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">blood-brain barrier</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">brain permeability</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pharmacology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">phenotypic drug screening</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Haemoparasites</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">animal reservoirs</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Trypanosoma growth inhibitors</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">pafuramidine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">acoziborole</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">African sleeping sickness</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">development of treatment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">suramin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">medical history</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">political history</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">clinical research</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">health system strengthening</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">South Sudan</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">diagnosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">symptoms</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">treatment-seeking</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">case detection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">embodiment</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">expertise</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">serendipity</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">CATT positive serological suspects</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">active follow-up strategy</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03928-963-2</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03928-964-0</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Burri, Christian</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:43:30 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&portfolio_pid=5338020210004498&Force_direct=true</subfield><subfield code="Z">5338020210004498</subfield><subfield code="b">Available</subfield><subfield code="8">5338020210004498</subfield></datafield></record></collection> |